The AACR and Bayer have been collaborating since 2015 to support the most promising and innovative cancer-focused research through different grant mechanisms. This partnership has yielded significant fruits, as indicated in this article.
The American Association for Cancer Research (AACR) is proud to announce a new collaboration with a grants program aimed at reducing the burden of cancer in Africa. In 2010, the U.S. National Cancer Institute (NCI) Center for Global Health (CGH), in partnership...
October is breast cancer awareness month. Researchers supported by the partnership between the AACR and the Triple-Negative Breast Cancer Foundation have made progress against triple-negative breast cancer on multiple fronts.
In recognition of the need to advance the science of lung cancer prevention and interception, the 2019 AACR-J&J Lung Cancer Innovation Science Grants program awarded grants to two multi-institutional teams whose multifaceted projects seek to understand how an individual’s genetics may affect smoking-related behaviors and quit attempts, as well as to develop clinically actionable smoking cessation strategies that will improve patient outcomes.
The AACR-Bristol Myers Squibb Midcareer Female Investigator Grant is the AACR’s first dedicated funding mechanism for midcareer scientists, as well as the first dedicated for women. The goal is to ensure that midcareer female researchers have the resources they need to successfully establish themselves as independent investigators with productive research labs.
Grantees Sahand Hormoz, PhD, and Robert Eil, MD, show the potential of out-of-the-box thinking as they pursue projects that take on major challenges in cancer research with the hope of transforming future clinical practice.
Since 2014, the American Association for Cancer Research (AACR) has invited early-career investigators to apply to the NextGen Stars program, which provides awardees the opportunity to present their research on a global stage at the AACR Annual Meeting. The enhanced visibility granted by the NextGen Stars program has helped prior recipients establish collaborations and receive constructive...
Kidney cancer is one of the most common cancers in the US. AACR has partnered with Kure It since 2012 to support innovative translational kidney cancer research. Researchers supported by this partnership have made progress against kidney cancer on multiple fronts.
Lung cancer remains the number one cause of cancer-related death. This persistent dismal prognosis has been largely attributed to late-stage diagnosis, when 5-year survival rates are less than 5%. Although the potential of lung cancer screening to reduce lung cancer-related mortality has been demonstrated, there remains a need for more effective and less invasive early detection methods. The AACR-Johnson & Johnson Lung Cancer Innovative Science Grants are fueling...
In 2019, Michael D. Story, PhD, was one of the inaugural recipients of the AACR-Novocure Tumor Treating Fields (TTFields) Research Grants Program. Now in 2020, he has the pleasure of seeing his mentee, Narasimha Kumar Karanam, PhD, receive an AACR-Novocure Career Development Award for Tumor Treating Fields Research.